A randomised controlled trial of intravenous steroids at home versus outpatients department for treatment of acute multiple sclerosis relapses

ISRCTN	ISRCTN95588376
DOI	https://doi.org/10.1186/ISRCTN95588376
Protocol serial number	N0263115172
Sponsor	Department of Health (UK)
Funder	University College London Hospitals NHS Trust (UK). NHS R&D Support Funding.

Prospectively registered

Protocol

Statistical analysis plan

Results

Individual participant data

Plain English summary of protocol

Not provided at time of registration

Ms B Porter
Scientific

Neurorehabilitation
National Hospital for Neurology & Neurosurgery
Queen Square
London
WC1N 3BG
United Kingdom

Primary study design	Interventional
Study design	Randomised controlled trial
Secondary study design	Randomised controlled trial
Scientific title
Study objectives	Is there a difference between patients and carer perception of management of MS relapse in outpatients department versus home?
Ethics approval(s)	Not provided at time of registration
Health condition(s) or problem(s) studied	Nervous System Diseases: Multiple sclerosis (MS)
Intervention	Treatment in outpatients department versus home
Intervention type	Other
Primary outcome measure(s)	Patient and carer perception of management of MS relapse.
Key secondary outcome measure(s)	Other measures include patients' safety, MS impact scores and cost of health case resources.
Completion date	01/12/2006

Participant type(s)	Patient
Age group	Not Specified
Sex	Not Specified
Target sample size at registration	164
Key inclusion criteria	164 Patients from Neurology.
Key exclusion criteria	Not provided at time of registration
Date of first enrolment	01/09/2002
Date of final enrolment	01/12/2006

Neurorehabilitation

London
WC1N 3BG
United Kingdom

Individual participant data (IPD) Intention to share	No
IPD sharing plan summary	Not provided at time of registration
IPD sharing plan

Output type	Details	Date created	Date added	Peer reviewed?	Patient-facing?
Results article	results	01/07/2006		Yes	No